PERSPECTA

News from every angle

← Back to headlines

Canaccord Increases Wave Life Sciences Price Target After Pipeline Review

Canaccord has raised its price target for Wave Life Sciences Ltd. (WVE) to $52 following a comprehensive review of the company's pipeline.

30 Mar, 11:40 — 30 Mar, 11:40
PostShare

Sources

Showing 1 of 1 sources
YahooMostly Factual9d ago

Edgewise Therapeutics, Inc. (EWTX) PT Increased to $45 at JPMorgan Amid Optimism on EDG-7500 Pipeline

Read full article →

Related Stories

Court of Appeals Affirms Dismissal of Ex-DBM Execs in Pharmally Scam

just now

PNP arrests six for oil pilferage in Laguna, Philippines

just now

Eastern Samar Town Bans Carabao Butchering Amid Rising Fuel Costs

just now

Former DPWH Engineer Accused of Using Borrowed License for P1.8B Deals

just now